RecruitingNot ApplicableNCT04490733

Developing Risk Prediction Model and Testing the Effect of Dual Task Walking on Improving Cognitive Function in Patients With Colorectal Cancer

Developing Risk Prediction Model of Mild Cognitive Impairment in Patients With Colorectal Cancer From Active Treatment to Survivor and Testing the Effect of Dual Task Walking on Improving Cognitive Function


Sponsor

National Taiwan University Hospital

Enrollment

355 participants

Start Date

Aug 17, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The aims of this three-year study are to explore cognitive function under different stages of colorectal cancer (CRC) and its related factors; and understand its disturbance and coping process caused by cancer-induced cognitive impairment (CICI) from patient perspective; and further to test effect of dual-task walking on improving cognitive function in CRC patients.


Eligibility

Min Age: 40 YearsMax Age: 75 Years

Inclusion Criteria1

  • Patients with newly diagnosed stage I to III colorectal cancer.

Exclusion Criteria1

  • Patients with cancer other than colorectal cancer or have cancer recurrence.

Interventions

BEHAVIORALdual-task walking

Participants in the experimental group will receive 3 times interventions during chemotherapy and 12 weekly phone calls or via LINE to assess barriers of dual-task walking.


Locations(1)

National Taiwan University

Taipei, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04490733


Related Trials